Bethlehem, PA – B. Braun Medical Inc. has issued a nationwide recall of two lots of intravenous solutions used widely in hospitals, citing the risk of particulate contamination inside containers.
According to the company and a notice posted by the U.S. Food and Drug Administration (FDA), the recall affects 1,000 mL bags of Lactated Ringers Injection USP and 0.9% Sodium Chloride Injection USP, both critical for hydration, fluid replacement and surgical care. The affected products were distributed to hospitals across the United States.
The recall applies specifically to:
- 0.9% Sodium Chloride Injection USP, 1000 mL – Lot #P000221280 (Exp. May 31, 2026)
- Lactated Ringers Injection USP, 1000 mL – Lot #P000221281 (Exp. May 31, 2026)
No injuries or adverse events have been reported. However, B. Braun said that if particulate matter is infused into a patient, it could travel into the circulatory system and lead to complications requiring medical intervention, with risks of impairment or death. If detected before use, hospitals may only experience a short delay while sourcing replacement fluids.
The FDA said healthcare providers should immediately check inventory, quarantine affected units and arrange for product return. Adverse reactions or quality issues may be reported to the FDA’s MedWatch program.
B. Braun, one of the nation’s largest suppliers of IV solutions, emphasized that patient safety remains its top priority as it works with distributors to remove recalled products from circulation.
The recall underscores the critical role of quality control in the U.S. medical supply chain, particularly for intravenous fluids that are essential to emergency and inpatient care nationwide.
This article was produced by a journalist and may include AI-assisted input. All content is reviewed for accuracy and fairness.
Follow us on Instagram & Facebook for more relevant new stories and SUPPORT LOCAL INDEPENDENT NEWS! Have a tip? Message us!
